Skip to Content Facebook Feature Image

Randstad Malaysia scales operations amid strong growth in permanent and flexible talent solutions

Business

Randstad Malaysia scales operations amid strong growth in permanent and flexible talent solutions
Business

Business

Randstad Malaysia scales operations amid strong growth in permanent and flexible talent solutions

2026-09-21 06:00 Last Updated At:07:15

KUALA LUMPUR, Malaysia, Sept. 21, 2026 /PRNewswire/ -- Randstad Malaysia, the globally leading recruitment and HR services agency, has expanded its physical footprint at Bangsar South, Kuala Lumpur, adding Level 5 to its existing office presence at Level 3A. The real estate expansion directly supports a 15% Year-on-Year (YoY) increase in internal headcount, reflecting sustained demand across both permanent recruitment and flexible workforce solutions despite broader regional macroeconomic caution.

The expansion comes on the back of a strong commercial performance in the first half of 2026, where Randstad Malaysia recorded a 25% Year-on-Year (YoY) increase in total revenue. This performance highlights growing demand across the agency's permanent recruitment, flexible contracting, and outsourced payroll desks as Malaysian enterprises rebuild their talent acquisition strategies.

TLDR ; Summary

  • Physical footprint expansion: Randstad Malaysia expands its Bangsar South presence by securing Level 5 alongside Level 3A to support a 15% YoY internal headcount growth.
  • Commercial growth: The firm posted a 25% YoY revenue growth in 1H 2026 across its permanent, contracting, and payrolling divisions.
  • Emerging industry desks: Specialised hiring capabilities were launched for high-growth verticals, including Data Centres, Renewable Energy, Banking, and Education.
  • Enterprise AI integration: Full deployment of AI across workflows has accelerated recruitment speed and candidate sourcing.

Link to image: https://drive.google.com/file/d/15E0u1VHXZhOygU1R4Hl7pr-iC1ErlFja/view?usp=sharing

Driving Total Workforce Agility Across Permanent and Flexible Desks

As business leaders across Malaysia navigate changing economic landscapes, organisations are increasingly seeking recruitment partners capable of delivering both long-term leadership stability and short-term operational agility. Randstad Malaysia's 25% revenue surge reflects a market-wide pivot towards total workforce strategies that balance permanent placements with agile, project-based talent.

Activity was particularly pronounced across the agency's specialised corporate recruitment areas, including Construction, Engineering, Supply Chain, Shared Services, and Technology. By offering comprehensive solutions across permanent placements, contract staffing, and managed payroll, Randstad enables employers to scale complex projects without incurring unnecessary fixed overheads.

"While extended decision-making cycles persist in the broader market, business opportunities remain abundant for companies agile enough to seize them. Organisations are moving away from rigid hiring frameworks in favour of total workforce strategies. By strengthening both our permanent recruitment and flexible contracting capabilities, we help clients secure critical executive leadership while maintaining the project-based agility required to scale."

— Fahad Naeem, Country Director at Randstad Malaysia

This dual approach aligns with findings from the Randstad Malaysia 2026 Market Outlook & Salary Guide, which reveals that 17% of local job seekers are actively open to contract roles. The trend is fueled by Gen Z professionals seeking diverse project exposure and senior talent pursuing specialised consultancy assignments.

Operational Scaling: Enterprise AI Sourcing and Strategic Specialisations

To support its physical and commercial growth, Randstad Malaysia focused its 1H 2026 operations on three core pillars: specialisation, internal talent development, and footprint expansion in emerging sectors.

The agency established specialised recruitment desks targeting high-growth industries, including Data Centres, Renewable Energy, Education, and Banking. Simultaneously, Randstad enhanced its service delivery by embedding AI into daily recruitment workflows.

Supporting Malaysia's High-Value Economic Transformation

The office expansion at Bangsar South positions Randstad Malaysia to better serve multinationals and domestic enterprises addressing specialised skill shortages. Data from the Randstad Malaysia Workmonitor 2026 shows that while 95% of local employers express confidence in their business growth trajectories, 52% of employees report taking on extra working hours or side roles to cushion cost-of-living pressures.

By expanding its consulting teams and infrastructure, Randstad Malaysia bridges the gap between corporate growth objectives and candidate career expectations across permanent, contract, and executive search functions.

Partner With Randstad For Data-Driven Talent Strategies

Randstad is the world's leading talent company with the vision to be the world's most equitable and specialized talent company. We are a partner of choice for talent and clients. We have a deep understanding of the labor market to help our clients create the high-quality, diverse and agile workforces they need to succeed.

Headquartered in the Netherlands, Randstad operates in 39 markets and has approximately 38,000 employees. In 2025, we supported nearly 150,000 clients and over 1.7 million talent, generating a revenue of €23.1 billion. Randstad N.V. is listed on the Euronext Amsterdam.

Partner with our recruitment specialists to gain access to more industry trends and secure your next key hire. Learn more by visiting Randstad Malaysia website at https://www.randstad.com.my/.

Liyana Yahaya
liyana.yahaya@randstad.com.my 
+60139577495
Marketing Lead - Randstad Malaysia & Singapore

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Randstad Malaysia scales operations amid strong growth in permanent and flexible talent solutions

Randstad Malaysia scales operations amid strong growth in permanent and flexible talent solutions

Late-breaking HRX data advance Field Medical's "instantaneous ablation" workflow and expand the clinical evidence for high-voltage focal PFA with the FieldForce™ PFA System

ATLANTA and CARLSBAD, Calif., Sept. 20, 2026 /PRNewswire/ -- Field Medical, Inc., advancing high-voltage focal pulsed field ablation (PFA) for complex arrhythmias, today announced publication of 12-month results from the first-in-human Field PULSE trial in JACC: Clinical Electrophysiology. The findings were presented simultaneously as a Late-Breaking Clinical Trial at HRX Live 2026.

Field Medical developed the FieldForce™ PFA System around a high-voltage focal PFA architecture designed first for the ventricle, where depth, stability and control are among the most difficult challenges in ablation. Field PULSE extends that work into the atrium and evaluates a subsecond point-by-point workflow Field Medical terms "instantaneous ablation." In this study, the approach was associated with procedural efficiency, durable pulmonary vein isolation (PVI) and flexibility beyond the pulmonary veins, without the need for prolonged catheter stability.

Key Findings:

  • Procedural efficiency with subsecond focal PFA: 13-minute median elapsed PVI ablation time, with a fastest time of 7.7 minutes
  • Durable PVI with the optimized waveform: 94.2% per-vein durability reflecting progressive improvement with waveform evolution
  • Flexible focal ablation: 49% of patients received non-PV ablation for additional atrial targets
  • No primary safety events were observed
  • 80% freedom from atrial arrhythmias at 12 months with the optimized waveform

"Field PULSE demonstrates the feasibility of truly instantaneous focal PFA," said Vivek Reddy, M.D., co-principal investigator, lead author and electrophysiologist at Mount Sinai Health System. "Delivering the full application in less than 200 milliseconds reduces the need for prolonged catheter stability while preserving the flexibility of point-by-point ablation. The procedural efficiency, safety and pulmonary vein durability observed with the optimized waveform support continued clinical development of this approach."

The publication builds on Field Medical's peer-reviewed clinical work in ventricular tachycardia. Six-month outcomes from the company's first-in-human VCAS trial were published in Circulation in 2025. Field PULSE now adds first-in-human, peer-reviewed atrial data evaluating the same high-voltage focal PFA architecture through a distinct focal workflow in a different cardiac substrate.

"We designed FieldForce to solve some of the hardest problems in focal cardiac ablation, beginning in the ventricle," said Mark A. Turco, M.D., president and chief executive officer of Field Medical. "Field PULSE demonstrates that the same high-voltage focal PFA architecture can support an 'instantaneous ablation' workflow in the atrium. This growing body of evidence reinforces the range of the platform: depth and focal control in the ventricle, speed and precision in the atrium, and the versatility to address very different cardiac substrates through a familiar point-by-point approach. These results add important clinical evidence as we continue to advance our differentiated PFA platform."

The study, "High-Voltage Focal PFA Catheter for 'Instant' Point-By-Point Ablation: The First-In-Human FIELD-PULSE Trial to Treat AF," was published online in JACC: Clinical Electrophysiology concurrent with the HRX presentation. DOI: 10.1016/j.jacep.2026.09.001.

About Field Medical®, Inc.
Field Medical is a clinical-stage medical technology company committed to advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias. The company was founded by Steven Mickelsen, M.D., CTO, a pioneer and global thought leader in PFA whose work has helped shape the evolution of the field. The FieldForce PFA System integrates a focal catheter design with proprietary FieldBending™ energy designed to safely deliver efficient, precise ablation with the goal of improving outcomes in ventricular and atrial arrhythmia treatment. In 2024, Field Medical earned Breakthrough Device Designation and gained entry into the FDA TAP Pilot Program for its ventricular tachycardia indication. In October 2025, the VCAS trial was published in Circulation.

For more information, visit fieldmedicalinc.com and follow us on LinkedIn and YouTube.

The FieldForce™ PFA System is an investigational device and is limited by federal (or United States) law to investigational use.

Media Contact
Holly Windler
619.929.1275
media@fieldmedicalinc.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform

JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform

Recommended Articles